Formulations of pimavanserin
AssigneeACADIA Pharmaceuticals Inc.
InventorsRavindra Tejwani, Stephen Edward Abele, Emanuel Joseph Vizzotti
Life of this patent
Estimating the term…
Abstract
Provided herein are capsules containing pimavanserin, processes for manufacturing said capsule, and pharmaceutical compositions containing pimavanserin.
Claims13
A pharmaceutically acceptable capsule for orally delivering 34 mg of pimavanserin to a patient, wherein the capsule has a size 3 or 4 capsule shell that contains a blended pimavanserin composition comprising:
- granules comprising 40 mg pimavanserin tartrate and optionally one or more pharmaceutically acceptable excipients;
- and one or more blending excipients;
- wherein the bulk density of the granules is >0.4 g/ml as determined by USP<616>, method 1.
A pharmaceutically acceptable capsule for orally delivering 34 mg of pimavanserin to a patient, wherein the capsule has a capsule shell with a capsule shell size 3 or 4, that encapsulates a blended pimavanserin composition comprising:
- granules comprising 40 mg pimavanserin tartrate and one or more pharmaceutically acceptable excipients;
- and
- wherein the bulk density of the granules is >0.4 g/ml as determined by USP<616>, method 1.
Dependencies are inferred from the claim text.